MYCN mediates cysteine addiction and sensitizes neuroblastoma to ferroptosis

Hamed Alborzinia(German Cancer Research Center), Frank Westermann(German Cancer Research Center), Moritz Gartlgruber(German Cancer Research Center), Andrés F. Flórez(Harvard University), Dorett I. Odoni(University of Augsburg), Elisa M. Wecht(German Cancer Research Center), Jürgen Burhenne(Heidelberg University), Sabine Stainczyk(German Cancer Research Center), Thomas Höfer(Heidelberg University), Maria Llamazares Prada(German Cancer Research Center), Matthias Ziehm(Max Delbrück Center), Marjan Shaikhkarami(Heidelberg University), Barbara Nicke(Target (Germany)), Jan H. Reiling(The University of Texas MD Anderson Cancer Center), Gernot Poschet(Heidelberg University), Matthias Selbach(Max Delbrück Center), Carl Herrmann(German Cancer Research Center), Ido Amit(Weizmann Institute of Science), Naveed Ishaque(Berlin Institute of Health at Charité - Universitätsmedizin Berlin), Jasmin Meier(German Cancer Research Center), Sina Kreth(German Cancer Research Center), Emma Bell(Ontario Institute for Cancer Research), Karolina Garbowicz(Heidelberg University), Jochen Kreth(German Cancer Research Center), Matthias Fischer(University of Cologne), Umut Yildiz(German Cancer Research Center), Matthias Schlesner(Radboud University Nijmegen), Franziska Paul(Weizmann Institute of Science), Stefan Wölfl(Institute of Molecular Biotechnology), Petra Zeisberger(German Cancer Research Center), Andreas Trumpp(German Cancer Research Center), Roberto Würth(Heidelberg Institute for Stem Cell Technology and Experimental Medicine), Lena Brückner(German Cancer Research Center), Corinna Klein(Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases), Michael Büttner(Heidelberg University), Kai‐Oliver Henrich(Heidelberg University), Michal Nadler-Holly(Max Delbrück Center), Chunxuan Shao(German Cancer Research Center), Carlo Stresemann(Bayer (Germany))
Nature Cancer
April 28, 2022
Cited by 224


Related Papers